Nrx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment For Nrx's Preservative-Free Ketamine Application April 6, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110946390/Nrx-Pharmaceuticals-NasdaqNRXP-Announces-FDA-Labeling-Alignment-For-Nrxs-Preservative-Free-Ketamine-Application
